Eric R Prossnitz

Title: Innovations by Inventor Eric R Prossnitz

Introduction

Eric R Prossnitz, an accomplished inventor based in Albuquerque, NM, has made significant contributions to the fields of molecular biology and pharmacology. With a total of 13 patents to his name, his work primarily focuses on innovative treatments for obesity, diabetes, and associated cardiovascular and kidney diseases.

Latest Patents

Among his recent inventions is a groundbreaking method for treating obesity, diabetes, cardiovascular, and kidney diseases by regulating GPR30/GPER activity. This invention provides a systematic approach that employs compounds to modulate the effects of GPR30/GPER. It emphasizes the use of agonists for treating obesity and diabetes, while potentially utilizing antagonists to address disease states resulting from excessive formation of reactive oxygen species (ROS). Through this patent, he showcases his intention to either stimulate or inhibit the disclosed estrogen receptor and help modulate the expression of NOX and NOX-associated reactive oxygen species.

Career Highlights

Throughout his career, Eric R Prossnitz has contributed to research and innovation while working at notable institutions such as STC.UNM and UNM Rainforest Innovations. His roles in these organizations have allowed him to collaborate effectively and push the boundaries of scientific research in his field.

Collaborations

Eric has worked alongside renowned colleagues like Larry A Sklar and Daniel F Cimino. Their collaborations have been instrumental in furthering their collective research efforts and advancing their contributions to medical science.

Conclusion

Eric R Prossnitz continues to be a relevant figure in the innovation landscape, particularly in studying and treating conditions related to obesity and diabetes. His extensive portfolio of patents exemplifies his commitment to finding solutions that address critical health issues, paving the way for future advancements in pharmacological treatments.